In this episode, Josh Hardman, the founder of Psychedelic Alpha, explores the multitude of challenges currently being encountered by the psychedelic industry. He engages in discussions regarding the progress of decriminalisation and legalisation initiatives, upcoming clinical trial milestones, and delves into the current state and the potential evolution of the Psychedelic industry.

Psychedelic Alpha

MDMA

Psilocybin

GHB

Cannabis

DMT

Psychoplastogens

MAPS

COMPASS Pathways

NICE

Oregon Psilocybin Services